PlumX Metrics
Embed PlumX Metrics

Switching treatment-experienced, integrase inhibitor-naïve, virally suppressed HIV-1 infected adults from ritonavir-boosted protease inhibitors to dolutegravir: design, methods, and baseline results of a randomized, open-label, non-inferiority trial

F1000Research, Vol: 11
2022
  • 0
    Citations
  • 0
    Usage
  • 2
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

F1000Research

Bibliographic Details

Jeremy Penner; Loice Ombajo; Joseph Nkuranga; Jared Mecha; Kevin Owuor; Collins Odhiambo; Margaret Mburu; Florentius Ndinya; Rukia Aksam; Richard Njenga; Simone Wahome; Peter Muiruri; Sheila Eshiwani; Maureen Kimani; Catherine Ngugi; Anton Pozniak

F1000 Research Ltd

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know